These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6114275)

  • 21. Antiarrhythmic effects of verapamil.
    Singh BN; Nademanee K; Feld G
    Angiology; 1983 Sep; 34(9):572-90. PubMed ID: 6351674
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological mapping of regional effects in the rabbit heart of some new antiarrhythmic drugs.
    Millar JS; Vaughan Williams EM
    Br J Pharmacol; 1983 Jul; 79(3):701-9. PubMed ID: 6652350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alinidine in heart patients: electrophysiologic and antianginal actions.
    Meinertz T; Kasper W; Jähnchen E
    Eur Heart J; 1987 Dec; 8 Suppl L():109-14. PubMed ID: 3330524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory action of 711389-S on the electrical activity of rabbit sinoatrial node.
    Kotake H; Hisatome I; Hasegawa J; Yamasaki J; Kosaka T; Furuse T; Mashiba H
    Cardiovasc Res; 1987 Mar; 21(3):197-201. PubMed ID: 3652085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual actions of the novel class III antiarrhythmic drug NE-10064 on delayed potassium channel currents in guinea pig ventricular and sinoatrial node cells.
    Davies MP; Freeman LC; Kass RS
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1149-54. PubMed ID: 8786546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiological effects of intravenous clonidine on sinus node function and conduction in man.
    Toussaint C; Cave D; Saoudi N; Moore N; Letac B
    J Cardiovasc Pharmacol; 1984; 6(1):56-60. PubMed ID: 6199612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of anti-arrhythmia agents in patients with pacemakers].
    Scanavacca M; Sosa EA; Martinelli Filho M
    Arq Bras Cardiol; 1988 Dec; 51(6):471-6. PubMed ID: 3076358
    [No Abstract]   [Full Text] [Related]  

  • 28. Selective effects of clonidine on the canine sinus node.
    Primm RK; Urthaler F; James TN
    J Pharmacol Exp Ther; 1980 Jul; 214(1):223-8. PubMed ID: 6104717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
    Camm AJ
    Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820
    [No Abstract]   [Full Text] [Related]  

  • 30. [Class-I antiarrhythmic drugs].
    Kuga K; Sugishita Y
    Nihon Rinsho; 1996 Aug; 54(8):2110-6. PubMed ID: 8810785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative chronotropic and parasympatholytic effects of alinidine on canine sinus node and AV junction.
    Hageman GR; Neely BH; Urthaler F; James TN
    Am J Physiol; 1985 Mar; 248(3 Pt 2):H324-30. PubMed ID: 3976903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisoquinoline.
    Dong H; Sheng JZ; Lee CM; Wong TM
    Br J Pharmacol; 1993 May; 109(1):113-9. PubMed ID: 8495235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Electrophysiological mechanisms of the anti-arrhythmia action of ethacizin].
    Malakhov VI; Golitsyn SP; Sokolov SF; Smetnev AS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):112-6. PubMed ID: 3541960
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical implications of new insights into mechanism of antiarrhythmic drug action.
    Meinertz T
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S23-7. PubMed ID: 1279305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electrophysiological effects of calcium-antagonists and their use in arrhythmia].
    Furlanello F; Disertori M; Vergara G; Molinis G; Guarnerio M; Stefenelli C
    Boll Soc Ital Cardiol; 1978; (1 Suppl):60-78. PubMed ID: 395963
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antiarrhythmic agents. Receptor hypothesis explains mechanisms of action].
    Bjørnstad H; Refsum H
    Tidsskr Nor Laegeforen; 1991 Oct; 111(26):3187-9. PubMed ID: 1658976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The cholinolytic activity of the new anti-arrhythmia preparation Nibentan].
    Fedorov VV; Vinogradova TM; Bogdanov KIu; Rozenshtraukh LV
    Ross Fiziol Zh Im I M Sechenova; 1999 Mar; 85(3):383-94. PubMed ID: 10494589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation].
    Kosior D; Szulc M; Zawadzka M; Pierścińska M; Stawicki S; Rabczenko D; Torbicki A; Opolski G
    Pol Arch Med Wewn; 2002 Dec; 108(6):1151-60. PubMed ID: 12687927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical pharmacology of alinidine and its side-effects.
    Shanks RG
    Eur Heart J; 1987 Dec; 8 Suppl L():83-90. PubMed ID: 3451887
    [No Abstract]   [Full Text] [Related]  

  • 40. Selectivity of alinidine, a bradycardic agent, for SA nodal automaticity versus other cardiac activities in isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):88-102. PubMed ID: 6517649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.